124 related articles for article (PubMed ID: 33067747)
21. Survival of cutaneous melanoma based on sex, age, and stage in the United States, 1992-2011.
Enninga EAL; Moser JC; Weaver AL; Markovic SN; Brewer JD; Leontovich AA; Hieken TJ; Shuster L; Kottschade LA; Olariu A; Mansfield AS; Dronca RS
Cancer Med; 2017 Oct; 6(10):2203-2212. PubMed ID: 28879661
[TBL] [Abstract][Full Text] [Related]
22. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
[TBL] [Abstract][Full Text] [Related]
23. Real-world use, safety, and survival of ipilimumab in metastatic cutaneous melanoma in The Netherlands.
Jochems A; Leeneman B; Franken MG; Schouwenburg MG; Aarts MJB; van Akkooi ACJ; van den Berkmortel FWPJ; van den Eertwegh AJM; Groenewegen G; de Groot JWB; Haanen JBAG; Hospers GAP; Kapiteijn E; Koornstra RH; Kruit WHJ; Louwman MWJ; Piersma D; van Rijn RS; Ten Tije AJ; Vreugdenhil G; Wouters MWJM; Uyl-de Groot CA; van der Hoeven KJM
Anticancer Drugs; 2018 Jul; 29(6):572-578. PubMed ID: 29659371
[TBL] [Abstract][Full Text] [Related]
24. Personal history of keratinocyte carcinoma is associated with reduced risk of death from invasive melanoma in men.
Song F; Chen ST; Li X; Han J
J Am Acad Dermatol; 2018 May; 78(5):957-963. PubMed ID: 29317282
[TBL] [Abstract][Full Text] [Related]
25. Primary cutaneous melanoma. Prognostic classification of anatomic location.
Garbe C; Büttner P; Bertz J; Burg G; d'Hoedt B; Drepper H; Guggenmoos-Holzmann I; Lechner W; Lippold A; Orfanos CE
Cancer; 1995 May; 75(10):2492-8. PubMed ID: 7736393
[TBL] [Abstract][Full Text] [Related]
26. Clinical and histopathologic predictors of survival in patients with malignant melanoma: a population-based study in Sweden.
Thörn M; Pontén F; Bergström R; Sparén P; Adami HO
J Natl Cancer Inst; 1994 May; 86(10):761-9. PubMed ID: 8169974
[TBL] [Abstract][Full Text] [Related]
27. Survival and Surgical Outcomes for Pediatric Head and Neck Melanoma.
Richards MK; Czechowicz J; Goldin AB; Gow KW; Doski J; Goldfarb M; Nuchtern J; Langer M; Beierle EA; Vasudevan S; Gupta D; Parikh SR
JAMA Otolaryngol Head Neck Surg; 2017 Jan; 143(1):34-40. PubMed ID: 27607058
[TBL] [Abstract][Full Text] [Related]
28. Gender differences in cutaneous melanoma: Demographics, prognostic factors, and survival outcomes.
Behbahani S; Maddukuri S; Cadwell JB; Lambert WC; Schwartz RA
Dermatol Ther; 2020 Nov; 33(6):e14131. PubMed ID: 32757248
[TBL] [Abstract][Full Text] [Related]
29. Impact of scalp location on survival in head and neck melanoma: A retrospective cohort study.
Xie C; Pan Y; McLean C; Mar V; Wolfe R; Kelly J
J Am Acad Dermatol; 2017 Mar; 76(3):494-498.e2. PubMed ID: 28413056
[TBL] [Abstract][Full Text] [Related]
30. Differences between pure desmoplastic melanoma and superficial spreading melanoma in terms of survival, distribution and other clinicopathologic features.
Howard MD; Wee E; Wolfe R; McLean CA; Kelly JW; Pan Y
J Eur Acad Dermatol Venereol; 2019 Oct; 33(10):1899-1906. PubMed ID: 31237040
[TBL] [Abstract][Full Text] [Related]
31. Outcomes of patients with local recurrence of cutaneous malignant melanoma: a population-based study.
Cohn-Cedermark G; Månsson-Brahme E; Rutqvist LE; Larsson O; Singnomklao T; Ringborg U
Cancer; 1997 Oct; 80(8):1418-25. PubMed ID: 9338465
[TBL] [Abstract][Full Text] [Related]
32. Association Between NRAS and BRAF Mutational Status and Melanoma-Specific Survival Among Patients With Higher-Risk Primary Melanoma.
Thomas NE; Edmiston SN; Alexander A; Groben PA; Parrish E; Kricker A; Armstrong BK; Anton-Culver H; Gruber SB; From L; Busam KJ; Hao H; Orlow I; Kanetsky PA; Luo L; Reiner AS; Paine S; Frank JS; Bramson JI; Marrett LD; Gallagher RP; Zanetti R; Rosso S; Dwyer T; Cust AE; Ollila DW; Begg CB; Berwick M; Conway K;
JAMA Oncol; 2015 Jun; 1(3):359-68. PubMed ID: 26146664
[TBL] [Abstract][Full Text] [Related]
33. Postdiagnosis aspirin use and overall survival in patients with melanoma.
Rachidi S; Wallace K; Li H; Lautenschlaeger T; Li Z
J Am Acad Dermatol; 2018 May; 78(5):949-956.e1. PubMed ID: 29317280
[TBL] [Abstract][Full Text] [Related]
34. Reduced disease-specific survival following a diagnosis of multiple primary cutaneous malignant melanomas-a nationwide, population-based study.
Utjés D; Lyth J; Lapins J; Eriksson H
Int J Cancer; 2017 Dec; 141(11):2243-2252. PubMed ID: 28799271
[TBL] [Abstract][Full Text] [Related]
35. Racial disparities in melanoma survival.
Dawes SM; Tsai S; Gittleman H; Barnholtz-Sloan JS; Bordeaux JS
J Am Acad Dermatol; 2016 Nov; 75(5):983-991. PubMed ID: 27476974
[TBL] [Abstract][Full Text] [Related]
36. Melanoma in children and teenagers: an analysis of patients from the National Cancer Data Base.
Lange JR; Palis BE; Chang DC; Soong SJ; Balch CM
J Clin Oncol; 2007 Apr; 25(11):1363-8. PubMed ID: 17416855
[TBL] [Abstract][Full Text] [Related]
37. Survival for patients with invasive cutaneous melanoma among ethnic groups: the effects of socioeconomic status and treatment.
Zell JA; Cinar P; Mobasher M; Ziogas A; Meyskens FL; Anton-Culver H
J Clin Oncol; 2008 Jan; 26(1):66-75. PubMed ID: 18165642
[TBL] [Abstract][Full Text] [Related]
38. Melanoma patterns of care in Ontario: A call for a strategic alignment of multidisciplinary care.
Look Hong NJ; Cheng SY; Baxter NN; Wright FC
J Surg Oncol; 2018 Mar; 117(4):597-617. PubMed ID: 29228470
[TBL] [Abstract][Full Text] [Related]
39. Optimal resection margin for head and neck cutaneous melanoma.
Han AY; Dhanjani S; Pettijohn K; Patel PB; John MAS
Laryngoscope; 2019 Jun; 129(6):1386-1394. PubMed ID: 30408184
[TBL] [Abstract][Full Text] [Related]
40. Is melanoma survival influenced by month of diagnosis?
Savoye I; Jegou D; Kvaskoff M; Rommens K; Boutron-Ruault MC; Coppieters Y; Francart J
Cancer Epidemiol; 2015 Oct; 39(5):727-33. PubMed ID: 26220880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
